Mesenchymal stem cells as treatment for behavioral deficits and neuropathology in the 5xFAD mouse model of Alzheimer’s disease

Jessica J. Matchynski-Franks, Colleen Pappas, Julien Rossignol, Tiffany Reinke, Kyle Fink, Andrew Crane, Alison Twite, Steven A. Lowrance, Cheng Song, Gary L. Dunbar

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

Alzheimer’s disease (AD) is characterized by a progressive loss of memory and other cognitive disturbances. The neuropathology of AD includes the major hallmarks of toxic amyloid-β oligomer accumulation and neurofibrillary tangles, as well as increased oxidative stress, cholinergic dysfunction, synapse loss, changes in endogenous neurotrophic factors, and overall degeneration of the brain. Adult mesenchymal stem cells (MSCs) offer the potential for a readily available treatment that would be long lasting, have low likelihood of rejection, and could target a variety of pathological deficits. MSCs have been shown to be effective in alleviating symptoms in some transgenic models of AD, but the optimal location for transplanting MSCs has yet to be determined. In the present study, the behavioral effects of transplantation of MSCs into the lateral ventricles, the hippocampus, or both of these regions were compared in the 5xFAD mouse model of AD. The results indicate that MSC transplants effectively reduce learning deficits in the 5xFAD mouse model and demonstrate a clear impact of MSCs on the levels of Aβ42 in the brains of 5xFAD mice. Overall, these findings support the hypothesis that MSCs may be a viable treatment for AD, especially when injected into the lateral ventricles.

Original languageEnglish (US)
Pages (from-to)687-703
Number of pages17
JournalCell Transplantation
Volume25
Issue number4
DOIs
StatePublished - Jan 1 2016
Externally publishedYes

Fingerprint

Stem cells
Mesenchymal Stromal Cells
Alzheimer Disease
Lateral Ventricles
Therapeutics
Brain
Mesenchymal Stem Cell Transplantation
Neurofibrillary Tangles
Adult Stem Cells
Poisons
Memory Disorders
Nerve Growth Factors
Transplants
Oxidative stress
Amyloid
Synapses
Cholinergic Agents
Neuropathology
Hippocampus
Oligomers

Keywords

  • Alzheimer’s disease (AD)
  • Amyloid-β protein precursor
  • Inflammation mesenchymal stem cells (MSCs)

ASJC Scopus subject areas

  • Biomedical Engineering
  • Cell Biology
  • Transplantation

Cite this

Mesenchymal stem cells as treatment for behavioral deficits and neuropathology in the 5xFAD mouse model of Alzheimer’s disease. / Matchynski-Franks, Jessica J.; Pappas, Colleen; Rossignol, Julien; Reinke, Tiffany; Fink, Kyle; Crane, Andrew; Twite, Alison; Lowrance, Steven A.; Song, Cheng; Dunbar, Gary L.

In: Cell Transplantation, Vol. 25, No. 4, 01.01.2016, p. 687-703.

Research output: Contribution to journalArticle

Matchynski-Franks, JJ, Pappas, C, Rossignol, J, Reinke, T, Fink, K, Crane, A, Twite, A, Lowrance, SA, Song, C & Dunbar, GL 2016, 'Mesenchymal stem cells as treatment for behavioral deficits and neuropathology in the 5xFAD mouse model of Alzheimer’s disease', Cell Transplantation, vol. 25, no. 4, pp. 687-703. https://doi.org/10.3727/096368916X690818
Matchynski-Franks, Jessica J. ; Pappas, Colleen ; Rossignol, Julien ; Reinke, Tiffany ; Fink, Kyle ; Crane, Andrew ; Twite, Alison ; Lowrance, Steven A. ; Song, Cheng ; Dunbar, Gary L. / Mesenchymal stem cells as treatment for behavioral deficits and neuropathology in the 5xFAD mouse model of Alzheimer’s disease. In: Cell Transplantation. 2016 ; Vol. 25, No. 4. pp. 687-703.
@article{9f8fb534f0e44272bd37c5cd0d0db8db,
title = "Mesenchymal stem cells as treatment for behavioral deficits and neuropathology in the 5xFAD mouse model of Alzheimer’s disease",
abstract = "Alzheimer’s disease (AD) is characterized by a progressive loss of memory and other cognitive disturbances. The neuropathology of AD includes the major hallmarks of toxic amyloid-β oligomer accumulation and neurofibrillary tangles, as well as increased oxidative stress, cholinergic dysfunction, synapse loss, changes in endogenous neurotrophic factors, and overall degeneration of the brain. Adult mesenchymal stem cells (MSCs) offer the potential for a readily available treatment that would be long lasting, have low likelihood of rejection, and could target a variety of pathological deficits. MSCs have been shown to be effective in alleviating symptoms in some transgenic models of AD, but the optimal location for transplanting MSCs has yet to be determined. In the present study, the behavioral effects of transplantation of MSCs into the lateral ventricles, the hippocampus, or both of these regions were compared in the 5xFAD mouse model of AD. The results indicate that MSC transplants effectively reduce learning deficits in the 5xFAD mouse model and demonstrate a clear impact of MSCs on the levels of Aβ42 in the brains of 5xFAD mice. Overall, these findings support the hypothesis that MSCs may be a viable treatment for AD, especially when injected into the lateral ventricles.",
keywords = "Alzheimer’s disease (AD), Amyloid-β protein precursor, Inflammation mesenchymal stem cells (MSCs)",
author = "Matchynski-Franks, {Jessica J.} and Colleen Pappas and Julien Rossignol and Tiffany Reinke and Kyle Fink and Andrew Crane and Alison Twite and Lowrance, {Steven A.} and Cheng Song and Dunbar, {Gary L.}",
year = "2016",
month = "1",
day = "1",
doi = "10.3727/096368916X690818",
language = "English (US)",
volume = "25",
pages = "687--703",
journal = "Cell Transplantation",
issn = "0963-6897",
publisher = "Cognizant Communication Corporation",
number = "4",

}

TY - JOUR

T1 - Mesenchymal stem cells as treatment for behavioral deficits and neuropathology in the 5xFAD mouse model of Alzheimer’s disease

AU - Matchynski-Franks, Jessica J.

AU - Pappas, Colleen

AU - Rossignol, Julien

AU - Reinke, Tiffany

AU - Fink, Kyle

AU - Crane, Andrew

AU - Twite, Alison

AU - Lowrance, Steven A.

AU - Song, Cheng

AU - Dunbar, Gary L.

PY - 2016/1/1

Y1 - 2016/1/1

N2 - Alzheimer’s disease (AD) is characterized by a progressive loss of memory and other cognitive disturbances. The neuropathology of AD includes the major hallmarks of toxic amyloid-β oligomer accumulation and neurofibrillary tangles, as well as increased oxidative stress, cholinergic dysfunction, synapse loss, changes in endogenous neurotrophic factors, and overall degeneration of the brain. Adult mesenchymal stem cells (MSCs) offer the potential for a readily available treatment that would be long lasting, have low likelihood of rejection, and could target a variety of pathological deficits. MSCs have been shown to be effective in alleviating symptoms in some transgenic models of AD, but the optimal location for transplanting MSCs has yet to be determined. In the present study, the behavioral effects of transplantation of MSCs into the lateral ventricles, the hippocampus, or both of these regions were compared in the 5xFAD mouse model of AD. The results indicate that MSC transplants effectively reduce learning deficits in the 5xFAD mouse model and demonstrate a clear impact of MSCs on the levels of Aβ42 in the brains of 5xFAD mice. Overall, these findings support the hypothesis that MSCs may be a viable treatment for AD, especially when injected into the lateral ventricles.

AB - Alzheimer’s disease (AD) is characterized by a progressive loss of memory and other cognitive disturbances. The neuropathology of AD includes the major hallmarks of toxic amyloid-β oligomer accumulation and neurofibrillary tangles, as well as increased oxidative stress, cholinergic dysfunction, synapse loss, changes in endogenous neurotrophic factors, and overall degeneration of the brain. Adult mesenchymal stem cells (MSCs) offer the potential for a readily available treatment that would be long lasting, have low likelihood of rejection, and could target a variety of pathological deficits. MSCs have been shown to be effective in alleviating symptoms in some transgenic models of AD, but the optimal location for transplanting MSCs has yet to be determined. In the present study, the behavioral effects of transplantation of MSCs into the lateral ventricles, the hippocampus, or both of these regions were compared in the 5xFAD mouse model of AD. The results indicate that MSC transplants effectively reduce learning deficits in the 5xFAD mouse model and demonstrate a clear impact of MSCs on the levels of Aβ42 in the brains of 5xFAD mice. Overall, these findings support the hypothesis that MSCs may be a viable treatment for AD, especially when injected into the lateral ventricles.

KW - Alzheimer’s disease (AD)

KW - Amyloid-β protein precursor

KW - Inflammation mesenchymal stem cells (MSCs)

UR - http://www.scopus.com/inward/record.url?scp=84962439244&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84962439244&partnerID=8YFLogxK

U2 - 10.3727/096368916X690818

DO - 10.3727/096368916X690818

M3 - Article

C2 - 26850119

AN - SCOPUS:84962439244

VL - 25

SP - 687

EP - 703

JO - Cell Transplantation

JF - Cell Transplantation

SN - 0963-6897

IS - 4

ER -